Anti-angiogenic peptides from the Nterminus of endostatin

Details for Australian Patent Application No. 2004269399 (hide)

Owner Children's Medical Center Corporation

Inventors Sjin, Robert Tjin Tham; Javaherian, Kashi; Folkman, Judah

Agent Shelston IP

Pub. Number AU-A-2004269399

PCT Pub. Number WO2005/021756

Priority 60/499,264 29.08.03 US; 60/539,213 26.01.04 US

Filing date 30 August 2004

Wipo publication date 10 March 2005

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

C07K 14/78 (2006.01) Peptides having more than 20 amino acids

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/021756 Priority application(s): WO2005/021756

31 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004269405-Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells

2004269395-Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations